Cantor Fitzgerald raises Ventas stock price target to $85 on senior housing strength

Published 31/10/2025, 15:28
Cantor Fitzgerald raises Ventas stock price target to $85 on senior housing strength

Investing.com - Cantor Fitzgerald raised its price target on Ventas (NYSE:VTR) to $85.00 from $77.00 on Friday, while maintaining an Overweight rating on the healthcare real estate investment trust. The new target represents a potential 14.4% upside from Ventas’s current price of $74.27. InvestingPro data shows VTR is trading near its 52-week high of $74.71, after delivering an impressive 29.03% return year-to-date.

The price target increase represents approximately a 28x multiple on Cantor Fitzgerald’s 2026 estimated adjusted funds from operations (AFFO) for the company.

According to Cantor Fitzgerald, Ventas currently trades at 25 times FactSet consensus 2026 estimated AFFO and at a 30% premium to FactSet consensus net asset value (NAV).

The firm noted that potential risks to achieving the new price target include any signs of stalling growth in the Senior Housing segment, which has been a key driver for Ventas.

Cantor Fitzgerald also highlighted that exposure to Life Science properties, while representing only 8% of Ventas’s portfolio, "remains a relative question market versus the outsized growth of Senior Housing."

In other recent news, Ventas Inc . reported its third-quarter 2025 earnings, surpassing analyst expectations. The company achieved an earnings per share (EPS) of $0.14, which was higher than the forecasted $0.09, representing a 55.56% surprise. Additionally, Ventas reported revenue of $1.49 billion, exceeding the anticipated $1.44 billion. These results highlight a strong performance for the quarter. There were no recent reports of mergers or acquisitions involving Ventas. Analyst notes regarding upgrades or downgrades of the stock were not mentioned in the recent updates. The company’s stock price movement was noted following the earnings announcement, but specific figures related to stock performance are not covered in this article.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.